SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience (OTCBB: PURE) today announced that Paul V. Maier has been appointed to the Board of Directors.
Michael L. Krall, President/CEO and Chairman of PURE Bioscience, commented, “Paul brings to PURE Bioscience more than 30 years of executive experience not only in pharmaceutical and biotechnology companies but also in consumer products companies. We expect to benefit from his expertise in strategic planning within rapid growth environments and from his extensive financial expertise, including Sarbanes-Oxley compliance management and audit and compensation committee experience. Paul will be instrumental in the formation and leadership of those committees for PURE Bioscience.”
